Who backs Bluejay Therapeutics?
13 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Novo Holdings | Other |
| Wellington Management | Asset manager |
| T. Rowe Price Group | — |
| Frazier Healthcare Partners | Venture capital |
| Octagon Capital Advisors | Hedge fund |
| Arkin Bio Ventures | — |
| HBM Healthcare Investments | — |
| InnoPinnacle | — |
| RiverVest Venture Partners | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Bluejay Therapeutics
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Bluejay Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.